Effect of publicly reporting performance data of medicine use on injection use: A quasi-experimental study

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Wang, Xuan ^a   Tang, Yuqing ^a   Zhang, Xiaopeng ^a   Yin, Xi ^a   Du, Xin ^a   Zhang, Xinping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINA; CONTROLLED STUDY; DRUG ABUSE; DRUG ADMINISTRATION; DRUG USE; FEMALE; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HUMAN; HUMAN EXPERIMENT; INAPPROPRIATE PRESCRIBING; INFORMATION PROCESSING; INJECTION; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL RESEARCH; NORMAL HUMAN; PRESCRIPTION; PUBLIC HEALTH SERVICE; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL; WORLD HEALTH ORGANIZATION; AGE; FACTUAL DATABASE; MIDDLE AGED; PRIMARY HEALTH CARE; RISK; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGE FACTORS; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PRIMARY HEALTH CARE; SEX FACTORS;

EID: 84907967437     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109594     Document Type: Article

References (41)

1. WHO Website. Medicines: Rational Use of Medicines. Available: http://www.who.int/mediacentre/factsheets/fs338/en/. Accessed: 2012 March.
2. le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM (1999) Intervention research in rational use of drugs: a review. Health policy and planning 14(2): 89-102.
3. Edwards IRAJ (2000) Adverse drug reactions: definitions, diagnosis, and management. The Lancet 356: 1255-1259.
4. Hu S, Chen W, Cheng X, Chen K, Zhou H, et al. (2001) Pharmaceutical cost-containment policy: experiences in Shanghai, China. Health Policy and Planning (Suppl 2): 4-9.
5. WHO (2009) Medicines Use in Primary Care in Developing and Transitional Countries: Fact Book Summarizing Results from Studies Reported between 1990 and 2006. Geneva, World Health Organization.
6. Yang L, Liu C, Ferrier JA, Zhou W, Zhang X (2013) The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy and Planning 28: 750-760.
7. Xiang X, Yang C, Wang D, Ye J, Zhang X (2012) Effects of China's national essential medicines policy on the use of injection in primary health facilities. Journal of Huazhong University of Science and Technology [Medical Sciences] 32: 626-629.
8. Sun Y, Fu W, Jia C, Lu Z (2005) Injection overuse situation in health service settings in rural area of Midwest part of china. Chinese J evidence-based medicine 5(5): 394-399.
9. Tang Y, Zhang X, Yang C, Yang L, Wang H, et al. (2013) Application of propensity scores to estimate the association between government subsidy and injection use in primary health care institutions in China. BMC Health Serv Res 13: 183.
10. WHO (1993) Action Programme on Essential Drugs. How to investigate drug use in health facilities. World Health Organization, Geneva: 1-87.
11. WHO (2002) Promoting rational use of medicines: core components. Geneva, World Health Organization.
12. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, et al. (2012) Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 6: D259.
13. Meeker D, Knight TK, Friedberg MW, Linder JA, Goldstein NJ, et al. (2014) Nudging Guideline-Concordant Antibiotic Prescribing. JAMA Internal Medicine 174: 425.
14. Gerber JS, Prasad PA, Fiks AG, Localio AR, Grundmeier RW, et al. (2013) Effect of an outpatient antimicrobial stewardship intervention on broadspectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 309: 2345-2352.
15. Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, et al. (2001) Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 108: 1-7.
16. Hibbard JH, Stockard J, Tusler M (2003) Does Publicizing Hospital Performance Stimulate Quality Improvement Efforts? Health Affairs 22: 84-94.
17. Faber M, Bosch M, Wollersheim H, Leatherman S, Grol R (2009) Public reporting in health care: How do consumers use quality-of-care information?: A systematic review. Medical care 47: 1-8.
18. Hannan EL, Kilburn H, Jr, Racz M, Shields E, et al. (1994) Improving the outcomes of coronary artery bypass surgery in new york state. JAMA 271: 761-766.
19. Snelling I (2003) Do star ratings really reflect hospital performance? Journal of Health Organisation and Management 17: 210-223.
20. Mainz J (2004) Nationwide continuous quality improvement using clinical indicators: the Danish National Indicator Project. International Journal for Quality in Health Care 16: i45-i50.
21. Fung CH, Lim YW, Mattke S, Damberg C, Shekelle PG (2008) Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann Intern Med 148: 111-123.
22. Tu JV, Cameron C (2003) Impact of an acute myocardial infarction report card in Ontario, Canada. Int J Qual Health Care 15: 131-137.
23. Lansky D (2002) Improving Quality Through Public Disclosure Of Performance Information. Health Affairs 21: 52-62.
24. Berwick DM, James B, Coye MJ (2003) Connections between quality measurement and improvement. Med Care 41: I30-I38.
25. Marshall MN, Shekelle PG, Davies HT, Smith PC (2003) Public reporting on quality in the United States and the United Kingdom. Health Aff (Millwood) 22: 134-148.
26. Blumenthal D, Epstein AM (1996) Quality of health care. Part 6: The role of physicians in the future of quality management. N Engl J Med 335: 1328-1331.
27. WHO (1993) How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Geneva, World Health Organization.
28. Wang H, Li N, Zhu H, Xu S, Lu H, et al. (2013) Prescription Pattern and Its Influencing Factors in Chinese County Hospitals: A Retrospective Cross-Sectional Study. PLoS ONE 8: e63225.
29. Li L (2010) Epidemiology. Beijing: People's Medical Publishing House. 122-123p.
30. Jin C, Li J, Chen L, Liang X (2012) Comparison of Internal Validity of Different Designs for Policy and Program Impact Evaluation. Chinese Health Economics 31(4): 79-82.
31. Dong L, Wang D, Gao J, Yan H (2011) Doctor's injection prescribing and its correlates in village health clinics across 10 Provinces of Western China. Journal of Public Health 33: 565-570.
32. Reynolds L, McKee M (2009) Factors influencing antibiotic prescribing in China: An exploratory analysis. Health Policy 90: 32-36.
33. Espeland WN, Sauder M (2007) Rankings and Reactivity: How Public Measures Recreate Social Worlds. American Journal of Sociology 113: 1-40.
34. Marshall MN, Shekelle PG, Leatherman S, Brook RH (2000) The public release of performance data: what do we expect to gain? A review of the evidence. JAMA 283: 1866-1874.
35. Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin EM, et al. (2007) Public Reporting and Pay for Performance in Hospital Quality Improvement. The New England Journal of Medicine 356: 486-496.
36. Broomberg J, Price MR (1990) The impact of the fee-for-service reimbursement system on the utilisation of health services. Part I. A review of the determinants of doctors' practice patterns. S Afr Med J 78: 130-132.
37. Li Y, Xu J, Wang F, Wang B, Liu L, et al. (2012) Overprescribing In China, Driven By Financial Incentives, Results In Very High Use Of Antibiotics, Injections, And Corticosteroids. Health Affairs 31: 1075-1082.
38. Shen J, Andersen R, Brook R, Kominski G, Albert PS, et al. (2004) The effects of payment method on clinical decision-making: physician responses to clinical scenarios. Med Care 42: 297-302.
39. WHO Website. Injection safety. Available: http://www.who.int/injection-safety/toolbox/en/InjectionFactSheet2002. Accessed: 2014 May.
40. Hadiyono JE, Suryawati S, Danu SS, Sunartono, Santoso B. (1996) Interactional group discussion: results of a controlled trial using a behavioral intervention to reduce the use of injections in public health facilities. Soc Sci Med 42: 1177-1183.
41. Bhunia R, Hutin Y, Ramkrishnan R, Ghosh PK, Dey S, et al. (2010) Reducing use of injections through interactional group discussions: a randomized controlled trial. Indian Pediatr 47: 409-414.